BAMCO INC /NY/
Q3 2021 13F-HR Holdings
Net value change ($000)
+470,443
(1.1%)
New positions
33
Sold out positions
36
Turnover %
3.8%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TSLA | 491,976 | 11.8% |
| IT | 322,077 | 24.0% |
| SMRT | 151,652 | NEW |
| MSCI | 149,588 | 12.8% |
| FDS | 146,079 | 16.2% |
| SPOT | 96,425 | 72.6% |
| ICLR | 85,047 | 61.3% |
| RRR | 83,696 | 25.8% |
| WST | 78,397 | 17.3% |
| NTRA | 73,013 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| GDS | -234,432 | -63.8% |
| BABA | -208,888 | -39.6% |
| WIX | -150,806 | -35.7% |
| ZLAB | -148,249 | -47.7% |
| ITUB | -114,591 | -100.0% |
| Zymergen Inc. | -106,675 | -100.0% |
| ZG | -106,168 | -28.4% |
| PRA Health Sciences, Inc. | -90,957 | -100.0% |
| IDXX | -90,238 | -5.3% |
| RNG | -87,094 | -25.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|